To Be Discontinued Tablet Hematology
Deferiprone Tablet · 308 days since initial FDA posting
Brand: FERRIPROX
FDA lists Deferiprone Tablet as To Be Discontinued (Chiesi USA, Inc.).
No availability text on this FDA row.
Deferiprone Tablet: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Deferiprone Tablet
- Manufacturer
- Chiesi USA, Inc.
- Dosage Form
- Tablet
- Presentation
- Ferriprox, Tablet, 500 mg (NDC 10122-100-10)
- Package NDC
- 10122-100-10
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Nov 7, 2025
- Last Updated
- Nov 7, 2025
- Therapeutic Category
- Hematology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug.
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.